Starting Pediatric VAD Program: Transforming Challenges into Opportunities; A Case Series of a Single Center.

IF 0.7 4区医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS

Heart Surgery Forum Pub Date : 2023-08-09 DOI:10.59958/hsf.5545

Matija Bakoš, Milivoj Novak, Dalibor Šarić, Dorotea Bartoniček, Dražen Belina, Željko Đurić, Darko Anić, Željko Čolak, Sanja Konosić, Marina Mihalec, Filip Rubić, Toni Matić, Goran Međimurec, Mislav Planinc

{"title":"Starting Pediatric VAD Program: Transforming Challenges into Opportunities; A Case Series of a Single Center.","authors":"Matija Bakoš, Milivoj Novak, Dalibor Šarić, Dorotea Bartoniček, Dražen Belina, Željko Đurić, Darko Anić, Željko Čolak, Sanja Konosić, Marina Mihalec, Filip Rubić, Toni Matić, Goran Međimurec, Mislav Planinc","doi":"10.59958/hsf.5545","DOIUrl":null,"url":null,"abstract":"Background: The prevalence of heart failure is constantly increasing in both children and adults. End-stage heart failure in children unresponsive to medical therapy has limited treatment options. Surgical options include heart transplantation or implantation of durable ventricular assist devices (VADs). To start the VAD program, it was necessary to train core team members, invite experienced proctors and adjust the organizational approach.Methods: We present our first seven pediatric patients who underwent a VAD implantation with primary indication end-stage dilated cardiomyopathy.Results: The median age on implant was four and a half years and the median duration of VAD support was 39 days with long term survival achieved in three patients. The causes of death were multiorgan failure, thromboembolic events, sepsis, and low cardiac output syndrome. Ischemic stroke was the reason for successful neurointervention during VAD support in two patients.Conclusions: To establish a VAD program, numerous specialties must be included with adequate training and learning for all team members.","PeriodicalId":51056,"journal":{"name":"Heart Surgery Forum","volume":"26 4","pages":"E326-E335"},"PeriodicalIF":0.7000,"publicationDate":"2023-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Surgery Forum","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.59958/hsf.5545","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The prevalence of heart failure is constantly increasing in both children and adults. End-stage heart failure in children unresponsive to medical therapy has limited treatment options. Surgical options include heart transplantation or implantation of durable ventricular assist devices (VADs). To start the VAD program, it was necessary to train core team members, invite experienced proctors and adjust the organizational approach.

Methods: We present our first seven pediatric patients who underwent a VAD implantation with primary indication end-stage dilated cardiomyopathy.

Results: The median age on implant was four and a half years and the median duration of VAD support was 39 days with long term survival achieved in three patients. The causes of death were multiorgan failure, thromboembolic events, sepsis, and low cardiac output syndrome. Ischemic stroke was the reason for successful neurointervention during VAD support in two patients.

Conclusions: To establish a VAD program, numerous specialties must be included with adequate training and learning for all team members.

查看原文本刊更多论文

启动儿科VAD项目:化挑战为机遇单中心的案例系列。

背景:儿童和成人心力衰竭的患病率都在不断上升。对药物治疗无反应的儿童终末期心力衰竭的治疗选择有限。手术选择包括心脏移植或植入持久心室辅助装置(VADs)。为了启动VAD计划，有必要培训核心团队成员，邀请有经验的监考人员并调整组织方法。方法:我们介绍了我们的第一个7例接受VAD植入的儿科患者，主要指征是终末期扩张型心肌病。结果:种植体的中位年龄为4岁半，VAD支持的中位持续时间为39天，3例患者实现长期生存。死亡原因为多器官衰竭、血栓栓塞事件、败血症和低心输出量综合征。缺血性卒中是两例患者在VAD支持期间神经干预成功的原因。结论:要建立VAD计划，必须包括许多专业，并为所有团队成员提供充分的培训和学习。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Heart Surgery Forum 医学-外科

CiteScore

1.20

自引率

16.70%

发文量

130

审稿时长

6-12 weeks

期刊介绍： The Heart Surgery Forum® is an international peer-reviewed, open access journal seeking original investigative and clinical work on any subject germane to the science or practice of modern cardiac care. The HSF publishes original scientific reports, collective reviews, case reports, editorials, and letters to the editor. New manuscripts are reviewed by reviewers for originality, content, relevancy and adherence to scientific principles in a double-blind process. The HSF features a streamlined submission and peer review process with an anticipated completion time of 30 to 60 days from the date of receipt of the original manuscript. Authors are encouraged to submit full color images and video that will be included in the web version of the journal at no charge.